LIFE SCIENCES CONSULTING

Life Sciences Industry Transformation and Strategic Support

The accelerated changes catalyzed by the COVID-19 pandemic, combined with breakthroughs in scientific innovation, digital technologies, and evolving business models, have fundamentally reshaped the life sciences industry. These advancements hold significant promise for improving patient care and unlocking new growth opportunities across the life sciences ecosystem.

However, this rapidly evolving and increasingly competitive landscape also presents several challenges. These include heightened pricing pressures, uncertain market access pathways, shifting consumer behaviors, and disruptions from nontraditional healthcare entrants. As a result, life sciences companies must strategically evaluate where to invest within their current portfolios and identify new avenues for growth.

At TNG, we partner with life sciences and pharmaceutical executives to develop practical, forward-looking strategies that enhance healthcare outcomes while ensuring success in a dynamic global market.

How We Support Our Clients

We collaborate with small, midsize, and multinational life sciences organizations to:

• Define and Execute Corporate Strategy: We help clients craft and implement customized strategies that drive sustainable, long-term value. Whether defining new business models, scaling franchises beyond initial products, evaluating adjacent markets, or strengthening leadership capabilities, our experienced team tailors approaches to each client’s unique circumstances.
   
• Expand into New Markets: We assist clients in entering and growing across geographies and market segments, including mature and emerging markets, prescription and consumer sectors, primary and specialty care, chronic, acute, and orphan disease spaces, and research, diagnostic, and therapeutic markets. Our market access strategies pave the way for sustained growth and value creation.
   
• Execute Value-Creating Deals: We support clients through the entire transaction lifecycle—from opportunity identification and evaluation to execution and post-merger integration. Our expertise spans in-licensing, out-licensing, strategic partnerships, M&A, joint ventures, divestitures, and royalty monetization, with over $140 billion in life sciences deals supported.
   
• Launch Innovative Products and Services: We partner with clients to develop and execute commercial launch strategies in both established and emerging markets. Our launch expertise covers pharmaceuticals, biopharmaceuticals, vaccines, life science tools, diagnostics, and enabling services such as CROs and CDMOs.
   
• Optimize Operations: We work alongside clients to enhance operational efficiency, organizational design, financial management, and process effectiveness across the life sciences value chain. Our interventions have driven productivity improvements and supported top- and bottom-line growth at corporate, business unit, and functional levels.